Fred Aslan

Company: Artiva Biotherapeutics, Inc

Job title: Chief Executive Officer

Seminars:

Panel Discussion: Exploring Current & Future Opportunities in Entering the Autoimmune Field as an NK Developer 9:00 am

What makes NK applications to the autoimmune space so exciting? Discussing recent advancements that showcase the promise of NK based therapy in autoimmune disease  Evaluating the main hurdles in expanding NKs to the autoimmune space Why is there more funding in autoimmunity than oncology?Read more

day: Pre-Conference Focus Day

Why NK Cells Versus Other Modalities in Autoimmune Disease? 10:00 am

Comparing and contrasting NK cell therapy as a modality to treat autoimmune disease as opposed to other cell therapies Evaluating NK cell therapy for autoimmune diseases versus oncologyRead more

day: Pre-Conference Focus Day